<html>
 <body>
  <div class="col-md-12" id="content" style="">
   <div class="hidden" data-drupal-messages-fallback="">
   </div>
   <div class="widget block" id="block-medsites-page-title">
    <h1>
     <span property="schema:name">
      DIC
     </span>
    </h1>
   </div>
   <div class="widget block" id="block-medsites-content">
    <article about="/commodorecompendium/dic" data-history-node-id="1028" role="article" typeof="schema:WebPage">
     <div>
      <div class="field field--name-body field--type-text-with-summary field--label-hidden field__item" property="schema:text">
       <div style="border-bottom:solid windowtext 1.0pt; border-top:double windowtext 1.5pt; border-left:none; border-right:none; padding:1.0pt 0in 1.0pt 0in">
        <p style="border:none; padding:0in">
         <span style="font-size:11pt">
          <span style="line-height:normal">
           <span style="font-family:Calibri,sans-serif">
            <b>
             <span style="font-size:12.0pt">
              <span style="font-family:Palatino">
               Disseminated
               <a id="DIC" name="DIC">
               </a>
               Intravascular Coagulation (DIC) - Eric Singhi
              </span>
             </span>
            </b>
           </span>
          </span>
         </span>
        </p>
       </div>
       <p>
        <span style="font-size:11pt">
         <span style="line-height:normal">
          <span style="font-family:Calibri,sans-serif">
           <span style="font-size:12.0pt">
            <span style="font-family:Palatino">
             Background
            </span>
           </span>
          </span>
         </span>
        </span>
       </p>
       <ul>
        <li>
         <span style="font-size:11pt">
          <span style="line-height:normal">
           <span style="font-family:Calibri,sans-serif">
            <span style="font-size:12.0pt">
             <span style="background:white">
              <span style="font-family:Palatino">
               <span style="color:black">
                Concurrent activation of the coagulation pathway and fibrinolytic pathway
               </span>
              </span>
             </span>
            </span>
           </span>
          </span>
         </span>
        </li>
        <li>
         <span style="font-size:11pt">
          <span style="line-height:normal">
           <span style="font-family:Calibri,sans-serif">
            <span style="font-size:12.0pt">
             <span style="background:white">
              <span style="font-family:Palatino">
               <span style="color:black">
                Widespread endothelial injury + exposure to circulating procoagulants
               </span>
              </span>
             </span>
            </span>
            <span style="font-size:12.0pt">
             <span style="background:white">
              <span style="font-family:Wingdings">
               <span style="color:black">
                
               </span>
              </span>
             </span>
            </span>
            <span style="font-size:12.0pt">
             <span style="background:white">
              <span style="font-family:Palatino">
               <span style="color:black">
                activation of coagulation cascade
               </span>
              </span>
             </span>
            </span>
            <span style="font-size:12.0pt">
             <span style="background:white">
              <span style="font-family:Wingdings">
               <span style="color:black">
                
               </span>
              </span>
             </span>
            </span>
            <span style="font-size:12.0pt">
             <span style="background:white">
              <span style="font-family:Palatino">
               <span style="color:black">
                thrombin production in small and medium-sized vessels
               </span>
              </span>
             </span>
            </span>
           </span>
          </span>
         </span>
        </li>
        <li>
         <span style="font-size:11pt">
          <span style="line-height:normal">
           <span style="font-family:Calibri,sans-serif">
            <span style="font-size:12.0pt">
             <span style="background:white">
              <span style="font-family:Palatino">
               <span style="color:black">
                Consumption of platelets, fibrin, and coagulation factors -> fibrinolysis -> end organ damage and hemolysis
               </span>
              </span>
             </span>
            </span>
           </span>
          </span>
         </span>
        </li>
        <li>
         <span style="font-size:11pt">
          <span style="line-height:normal">
           <span style="font-family:Calibri,sans-serif">
            <span style="font-size:12.0pt">
             <span style="background:white">
              <span style="font-family:Palatino">
               <span style="color:black">
                Etiologies:
               </span>
              </span>
             </span>
            </span>
           </span>
          </span>
         </span>
         <ul style="list-style-type:circle">
          <li>
           <span style="font-size:11pt">
            <span style="line-height:normal">
             <span style="tab-stops:9.0pt">
              <span style="font-family:Calibri,sans-serif">
               <span style="font-size:12.0pt">
                <span style="background:white">
                 <span style="font-family:Palatino">
                  <span style="color:black">
                   Infection/Sepsis, Liver disease, Pancreatitis, Trauma
                  </span>
                 </span>
                </span>
               </span>
              </span>
             </span>
            </span>
           </span>
          </li>
          <li>
           <span style="font-size:11pt">
            <span style="line-height:normal">
             <span style="tab-stops:9.0pt">
              <span style="font-family:Calibri,sans-serif">
               <span style="font-size:12.0pt">
                <span style="background:white">
                 <span style="font-family:Palatino">
                  <span style="color:black">
                   Malignancies: mucin-secreting pancreatic/gastric adenocarcinoma, brain tumors, prostate cancer, all acute leukemias, acute promyelocytic leukemia
                  </span>
                 </span>
                </span>
               </span>
              </span>
             </span>
            </span>
           </span>
          </li>
          <li>
           <span style="font-size:11pt">
            <span style="line-height:normal">
             <span style="tab-stops:9.0pt">
              <span style="font-family:Calibri,sans-serif">
               <span style="font-size:12.0pt">
                <span style="background:white">
                 <span style="font-family:Palatino">
                  <span style="color:black">
                   Obstetric complications (i.e. preeclampsia/eclampsia, placental abruption)
                  </span>
                 </span>
                </span>
               </span>
              </span>
             </span>
            </span>
           </span>
          </li>
          <li>
           <span style="font-size:11pt">
            <span style="line-height:normal">
             <span style="tab-stops:9.0pt">
              <span style="font-family:Calibri,sans-serif">
               <span style="font-size:12.0pt">
                <span style="background:white">
                 <span style="font-family:Palatino">
                  <span style="color:black">
                   Acute hemolytic transfusion reaction (i.e. ABO incompatible transfusion)
                  </span>
                 </span>
                </span>
               </span>
              </span>
             </span>
            </span>
           </span>
          </li>
         </ul>
        </li>
       </ul>
       <p>
       </p>
       <p>
        <span style="font-size:11pt">
         <span style="line-height:107%">
          <span style="font-family:Calibri,sans-serif">
           <span style="font-size:12.0pt">
            <span style="background:white">
             <span style="font-family:Palatino">
              <span style="color:black">
               Evaluation
              </span>
             </span>
            </span>
           </span>
          </span>
         </span>
        </span>
       </p>
       <ul>
        <li>
         <span style="font-size:11pt">
          <span style="line-height:normal">
           <span style="font-family:Calibri,sans-serif">
            <span style="font-size:12.0pt">
             <span style="background:white">
              <span style="font-family:Palatino">
               <span style="color:black">
                Exam:  petechiae, bleeding (mucosal, IV site, surgical wound site, hematuria), ecchymoses, thrombosis (i.e. cold, pulseless extremities)
               </span>
              </span>
             </span>
            </span>
           </span>
          </span>
         </span>
        </li>
        <li>
         <span style="font-size:11pt">
          <span style="line-height:normal">
           <span style="font-family:Calibri,sans-serif">
            <span style="font-size:12.0pt">
             <span style="background:white">
              <span style="font-family:Palatino">
               <span style="color:black">
                CBC,  PT/INR, aPTT, Fibrinogen, D-Dimer, Peripheral Blood Smear
               </span>
              </span>
             </span>
            </span>
           </span>
          </span>
         </span>
        </li>
        <li>
         <span style="font-size:11pt">
          <span style="line-height:normal">
           <span style="font-family:Calibri,sans-serif">
            <span style="font-size:12.0pt">
             <span style="background:white">
              <span style="font-family:Palatino">
               <span style="color:black">
                “DIC labs” = q6h fibrinogen, PT/INR, aPTT (space out when lower risk)
               </span>
              </span>
             </span>
            </span>
           </span>
          </span>
         </span>
        </li>
        <li>
         <span style="font-size:11pt">
          <span style="line-height:normal">
           <span style="font-family:Calibri,sans-serif">
            <span style="font-size:12.0pt">
             <span style="background:white">
              <span style="font-family:Palatino">
               <span style="color:black">
                Findings suggestive of DIC: thrombocytopenia, prolonged aPTT and PT/INR, hypofibrinogenemia, elevated D-dimer, fibrin degradation products, schistocytes
               </span>
              </span>
             </span>
            </span>
           </span>
          </span>
         </span>
        </li>
       </ul>
       <p>
       </p>
       <p>
        <span style="font-size:11pt">
         <span style="line-height:normal">
          <span style="font-family:Calibri,sans-serif">
           <span style="font-size:12.0pt">
            <span style="font-family:Palatino">
             Management
            </span>
           </span>
          </span>
         </span>
        </span>
       </p>
       <ul>
        <li>
         <span style="font-size:11pt">
          <span style="line-height:normal">
           <span style="font-family:Calibri,sans-serif">
            <span style="font-size:12.0pt">
             <span style="background:white">
              <span style="font-family:Palatino">
               <span style="color:black">
                Treat the underlying cause!
               </span>
              </span>
             </span>
            </span>
           </span>
          </span>
         </span>
        </li>
        <li>
         <span style="font-size:11pt">
          <span style="line-height:normal">
           <span style="font-family:Calibri,sans-serif">
            <span style="font-size:12.0pt">
             <span style="background:white">
              <span style="font-family:Palatino">
               <span style="color:black">
                Hemodynamic support (i.e. hypotension): Intravenous fluid resuscitation
               </span>
              </span>
             </span>
            </span>
           </span>
          </span>
         </span>
        </li>
        <li>
         <span style="font-size:11pt">
          <span style="line-height:normal">
           <span style="font-family:Calibri,sans-serif">
            <span style="font-size:12.0pt">
             <span style="background:white">
              <span style="font-family:Palatino">
               <span style="color:black">
                Vitamin K for INR > 1.7 or bleeding
               </span>
              </span>
             </span>
            </span>
           </span>
          </span>
         </span>
        </li>
        <li>
         <span style="font-size:11pt">
          <span style="line-height:normal">
           <span style="font-family:Calibri,sans-serif">
            <span style="font-size:12.0pt">
             <span style="background:white">
              <span style="font-family:Palatino">
               <span style="color:black">
                If bleeding consider FFP, Vitamin K to correct coagulopathy
               </span>
              </span>
             </span>
            </span>
           </span>
          </span>
         </span>
        </li>
        <li>
         <span style="font-size:11pt">
          <span style="line-height:normal">
           <span style="font-family:Calibri,sans-serif">
            <span style="font-size:12.0pt">
             <span style="background:white">
              <span style="font-family:Palatino">
               <span style="color:black">
                Hypofibrinogenemia treatment: Cryoprecipitate 5-10 units if fibrinogen < 100
               </span>
              </span>
             </span>
            </span>
           </span>
          </span>
         </span>
        </li>
        <li>
         <span style="font-size:11pt">
          <span style="line-height:normal">
           <span style="font-family:Calibri,sans-serif">
            <span style="font-size:12.0pt">
             <span style="background:white">
              <span style="font-family:Palatino">
               <span style="color:black">
                Thrombocytopenia treatment: plt transfusion as normally indicated
               </span>
              </span>
             </span>
            </span>
           </span>
          </span>
         </span>
        </li>
        <li>
         <span style="font-size:11pt">
          <span style="line-height:normal">
           <span style="font-family:Calibri,sans-serif">
            <span style="font-size:12.0pt">
             <span style="background:white">
              <span style="font-family:Palatino">
               <span style="color:black">
                DVT ppx if not bleeding and plt > 50
               </span>
              </span>
             </span>
            </span>
           </span>
          </span>
         </span>
        </li>
        <li>
         <span style="font-size:12.0pt">
          <span style="background:white">
           <span style="line-height:107%">
            <span style="font-family:Palatino">
             <span style="color:black">
              VTE: anticoagulation if plt > 50 and no massive bleeding
             </span>
            </span>
           </span>
          </span>
         </span>
        </li>
       </ul>
      </div>
     </div>
    </article>
   </div>
  </div>
 </body>
</html>